Gut Bacteria as Medicine: Microbiome Therapies Rewriting
FDA-approved microbiome therapies like Rebyota and Vowst are curing recurrent infections with 85-90% success rates by restoring beneficial gut bacteria. Over 180 microbiome-based drugs are in development for conditions ranging from inflammatory bowel disease to mental health disorders. Scientists can now identify which bacterial strains promote health versus disease, engineer probiotics to deliver therapeutic payloads, and use AI to design personalized microbial cocktails. Within a decade, mi...
